Cargando…

Quantification of newly produced B and T lymphocytes in untreated chronic lymphocytic leukemia patients

BACKGROUND: The immune defects occurring in chronic lymphocytic leukemia are responsible for the frequent occurrence of infections and autoimmune phenomena, and may be involved in the initiation and maintenance of the malignant clone. Here, we evaluated the quantitative defects of newly produced B a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Motta, Marina, Chiarini, Marco, Ghidini, Claudia, Zanotti, Cinzia, Lamorgese, Cinzia, Caimi, Luigi, Rossi, Giuseppe, Imberti, Luisa
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991330/ https://www.ncbi.nlm.nih.gov/pubmed/21054858 http://dx.doi.org/10.1186/1479-5876-8-111

Ejemplares similares

Modulation of Regulatory T-Cell Subsets in Very Long-Term Treated Aviremic HIV(+) Patients and Untreated Viremic Patients
por: Serana, Federico, et al.
Publicado: (2014)

T-cell Receptor and K-deleting Recombination Excision Circles in Newborn Screening of T- and B-cell Defects: Review of the Literature and Future Challenges
por: Chiarini, Marco, et al.
Publicado: (2013)

Pre-Existing T- and B-Cell Defects in One Progressive Multifocal Leukoencephalopathy Patient
por: Sottini, Alessandra, et al.
Publicado: (2012)

Use of V(D)J recombination excision circles to identify T- and B-cell defects and to monitor the treatment in primary and acquired immunodeficiencies
por: Serana, Federico, et al.
Publicado: (2013)

Detection of newly produced T and B lymphocytes by digital PCR in blood stored dry on nylon flocked swabs
por: Tessitore, Marion Vaglio, et al.
Publicado: (2017)

Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1(+) patients
por: Quiros-Roldan, Eugenia, et al.
Publicado: (2012)

B- and T-lymphocyte number and function in HIV(+)/HIV(−) lymphoma patients treated with high-dose chemotherapy and autologous bone marrow transplantation
por: Bertoli, Diego, et al.
Publicado: (2016)

Postremission sequential monitoring of minimal residual disease by WT1 Q‐PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk‐adapted therapy in acute myeloid leukemia patients
por: Malagola, Michele, et al.
Publicado: (2015)

Reduced T-cell repertoire restrictions in abatacept-treated rheumatoid arthritis patients
por: Imberti, Luisa, et al.
Publicado: (2015)

A Case of Acute Myeloid Leukemia Concurrent With Untreated Chronic Lymphocytic Leukemia
por: Lee, Hye-Young, et al.
Publicado: (2017)

Rapid Progression of Pulmonary Blastomycosis in an Untreated Patient of Chronic Lymphocytic Leukemia
por: Sarkar, Pralay K., et al.
Publicado: (2014)

Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia
por: Hill, Brian T, et al.
Publicado: (2015)

Blastoschizomyces capitatus pneumonia in a patient with untreated chronic lymphocytic leukemia
por: Trovato, Laura, et al.
Publicado: (2018)

Genetic polymorphisms, chronic lymphocytic leukemia, and the future: are we there yet?
por: Caimi, Paolo F., et al.
Publicado: (2014)

Type I interferon-dependent gene MxA in perinatal HIV-infected patients under antiretroviral therapy as marker for therapy failure and blood plasmacytoid dendritic cells depletion
por: Badolato, Raffaele, et al.
Publicado: (2008)

Chronic lymphocytic leukemia
por: Rossi, Davide
Publicado: (2018)

Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia.
por: Gora-Tybor, Joanna, et al.
Publicado: (2003)

Obinutuzumab: A FDA approved monoclonal antibody in the treatment of untreated chronic lymphocytic leukemia
por: Sachdeva, Mamta, et al.
Publicado: (2015)

The prognostic impact of lymphocyte subsets in newly diagnosed acute myeloid leukemia
por: Park, Yumi, et al.
Publicado: (2018)

Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL)
por: Al-Kali, Aref, et al.
Publicado: (2010)

Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia
por: Griggio, Valentina, et al.
Publicado: (2016)

A phase II Japanese trial of fludarabine, cyclophosphamide and rituximab for previously untreated chronic lymphocytic leukemia
por: Izutsu, Koji, et al.
Publicado: (2020)

Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis.
por: Wedelin, C., et al.
Publicado: (1982)

Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients
por: Hoffmann, Jean-Marc, et al.
Publicado: (2018)

Decreased deformability of lymphocytes in chronic lymphocytic leukemia
por: Zheng, Yi, et al.
Publicado: (2015)

Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantation
por: Skert, Cristina, et al.
Publicado: (2017)

A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia
por: Kay, Neil E., et al.
Publicado: (2016)

Albumin-to-Fibrinogen Ratio as an Independent Prognostic Parameter in Untreated Chronic Lymphocytic Leukemia: A Retrospective Study of 191 Cases
por: Zou, Yi-Xin, et al.
Publicado: (2019)

S145: VENETOCLAX-OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 6-YEAR RESULTS OF THE RANDOMIZED CLL14 STUDY
por: Al-Sawaf, Othman, et al.
Publicado: (2023)

The Spectrum of Genetic Defects in Chronic Lymphocytic Leukemia
por: Rossi, Davide, et al.
Publicado: (2012)

Newly Diagnosed Chronic Lymphocytic Leukemia During Symptomatic COVID-19: Two Cases
por: Papp, Enikő, et al.
Publicado: (2022)

Chronic Lymphocytic Leukemia
por: Vaisitti, Tiziana, et al.
Publicado: (2020)

Cytoplasmic crystal inclusions in lymphocytes of chronic lymphocytic leukemia
por: Villuendas Vázquez, Òscar, et al.
Publicado: (2020)

Hepatitis E and Lymphocytic Leukemia in Man, Italy
por: Giordani, Maria T., et al.
Publicado: (2013)

Overview of non‐coding mutations in chronic lymphocytic leukemia
por: Spina, Valeria, et al.
Publicado: (2019)

A Two-Gene Signature, SKI and SLAMF1, Predicts Time-to-Treatment in Previously Untreated Patients with Chronic Lymphocytic Leukemia
por: Schweighofer, Carmen D., et al.
Publicado: (2011)

Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the phase IIIb GREEN study
por: Leblond, Véronique, et al.
Publicado: (2018)

Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study
por: Bosch, Francesc, et al.
Publicado: (2019)

Intracytoplasmic crystalline inclusions in chronic lymphocytic leukemia
por: Ramlal, Bharat, et al.
Publicado: (2019)

Altered peripheral lymphocyte subsets in untreated systemic lupus erythematosus patients with infections
por: Lu, Zhimin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1e65jjk6m733k5lhajc4ujjdfn